News
Don't Be Fooled By Badger Meter's Rise, There's More To Go
Badger Meter (NYSE: BMI) stock is risng by as much as 6.2% during Thursday's trading session; markets are beginning to react to the set perceptions in the company, especially after reporting
How the NASDAQ 100 Special Rebalancing Will Hurt Performance
On July 7, 2023, the Nasdaq announced it would implement a special rebalancing for the Nasdaq 100 index, tracked by the Invesco QQQ ETF (NASDAQ: QQQ) effective after hours on July 21, 2023, and
Zillow’s Stock Is Hot...The Housing Market Is Not
Up more than 70% this year, Zillow Group, Inc. (NASDAQ:ZG) is one of the hottest technology stocks — and yet it's not exactly making a big splash.
In a market focused on artificial intelligence
JetBlue Ends Alliance With American, Chance Of Spirit Merger?
JetBlue Airlines (NASDAQ: JBLU) stock is declining by as much as 6.5% during Thursday's trading session, even after initially positive news regarding a tough but strategic decision by management
New Name, Coherent is a Compelling AI Data Infrastructure Play
Laser systems maker Coherent Co. (NASDAQ: COHR) changed its name from II-VI, confusing investors even trying to pronounce the name. The company is undergoing a multi-year restructuring plan to
$1 Billion Deal For Moderna To Expand Product Pipeline in China
The defensive stocks sector has been underperforming most - if not all - of the remaining cyclical sectors in the U.S. economy. These preferences come from underlying dynamics in the money markets
Moderna kündigt weltweite Zulassungsanträge für seinen Impfstoff MRNA-1345 gegen das Respiratorische Synzytial-Virus (RSV) an
- Moderna hat Zulassungsanträge für den RSV-Prüfimpfstoff mRNA-1345 bei der Europäischen Arzneimittelagentur, bei Swissmedic und bei der Therapeutic Goods Administration in
Moderna Announces Global Regulatory Submissions for Its Respiratory Syncytial Virus (RSV) Vaccine, MRNA-1345
- Moderna has submitted marketing authorization applications for the investigational RSV vaccine, mRNA-1345, with the European Medicines Agency, Swissmedic, and the Therapeutic Goods
Overstock Looks Beyond Overbought After Bed Bath Re-Brand
What do online home furnisher Overstock.com, Inc. (NASDAQ:OSTK) and clothing retailer Burlington Stores have in common? Both are turning to the bankrupt Bed Bath & Beyond to generate inexpensive
Moderna Submits Regulatory Application to the European Medicines Agency for Its Updated COVID-19 Vaccine
The filing follows the recommendation from regulators and global public health bodies to develop monovalent XBB.1.5 COVID-19 vaccines
Pending approval, Moderna's updated COVID-19 vaccine
Moderna reicht Zulassungsantrag für seinen neu angepassten COVID-19-Impfstoff bei der Europäischen Arzneimittelagentur ein
Die Einreichung folgt auf die Empfehlung der Regulierungsbehörden und öffentlichen Gesundheitseinrichtungen auf internationaler Ebene hinsichtlich der Entwicklung von monovalenten
Moderna: Declining Performance And Relative Weakness
Moderna (NASDAQ: MRNA) was the top-performing stock in the S&P 500 not too long ago when the company joined the index in mid-2021. At its peak in 2021, the company's value soared to $187 billion
MongoDB: An AI Play That’s About To Boil Over
MongoDB (NASDAQ: MDB) emerged as an AI play when it released FQ1 earnings in early June. The company beat on the top and bottom lines and issued clear guidance saying it was well-positioned to
AI-Powered Dropbox Sees Stock Soar: A Comeback in the Making?
A few years ago, Dropbox Inc. (NASDAQ: DBX) was the rage as the hot productivity tool to help business users organize files.
Is the stock recapturing some of its former glory as it joins the
Can Barbie and the New MCU Rescue Mattel Stock?
Family entertainment company Mattel, Inc. (NYSE: MAT) stock has languished in 2023, up 2% on the year, underperforming the S&P 500 index, up 15%. The upcoming Barbie movie scheduled to release in
Roku's Recent Gains Bring Hope Amidst Slump In Streaming Giant
Roku (NASDAQ: ROKU), a former high-flying growth name during the pandemic, has significantly faded off its ATHs of $490.76, set back in July 2021. The stock has faded about 85% from that high
Why Mosaic's Price Targets May Be Understated
Shares of Mosaic (NYSE: MOS) have been on a steady downtrend since their peak price of $79.28 per share in April 2022. The decline had only accelerated with a more substantial fall lasting for the
Amazon And The AI War: iRobot Acquisition In Focus
A war is happening in the tech world, and Amazon (NASDAQ: AMZN) is not sitting idly by. The company commands 30% of the data-center market shares and faces increased competition from names like
G-III, PVH, Ralph Lauren: Promising Charts Even As Revenue Slows
The American consumer is giving mixed signals when it comes to apparel spending, but clothing companies G-III Apparel Group Ltd. (NASDAQ: GIII), PVH Corp. (NYSE: PVH) and Ralph Lauren Corp. (NYSE:
Can The Digital Economy Revive DocuSign Stock?
Shares of DocuSign (NASDAQ: DOCU) advanced in the after-market hours of Thursday evening, hitting as high a price as $67 per share for a whopping 14.5% rally. The initial reactions are attributed
3 High-Yield Values Ready To Rebound
High yields are attractive but can be a red flag for investors. Marketbeat.com’s list of High Yield stocks has many names that cannot sustain their high yields, have already cut their
Sleeper AI-Play MongoDB Could Triple In Size
MongoDB (NASDAQ: MDB) was on virtually no one's radar as an AI play, yet it is. The company’s cloud-based database services and developer data tools make it perfectly positioned to benefit from
Nordstrom's Earnings Beat, A Rally In The Making
Shares of Nordstrom (NYSE: JWN) are trading higher by nearly 2% on Thursday's trading session on the back of adjusted earnings per share beat. While
PVH: Is This Value Back In Style?
PVH Corporation (NYSE: PVH) shares pulled back in the wake of the Q1 release and guidance, which begs the question, is the value a buy? The stock is certainly a value compared to peers like Ralph
Elliott Management Says Goodyear Tire Worth At Least $21 a Share
The Goodyear Tire and Rubber Company (NYSE: GT) stock has been choppy between $9.66 and $12.50 until the last seven months when activist investor Elliott Management called out the board of